Fierce Pharma Biopharma News & Insights
2024年12月19日 · Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
Top 20 pharma companies by 2023 revenue - Fierce Pharma
2024年4月15日 · There were changes at the top and the bottom of last year’s top 20 pharma rankings by revenue. And, in between, Novo Nordisk made a significant leap, jumping five spots propelled by skyrocketing ...
Top 10 most anticipated drug launches of 2024 | Fierce Pharma
2024年1月29日 · Every year, we tap Evaluate's annual preview report to assess the biggest potential new drugs of the year ahead. Typically, major pharmaceutical and biotechnology companies are featured, each ...
The top 20 drugs by worldwide sales in 2023 | Fierce Pharma
2024年5月28日 · It's been several years since COVID-19 vaccines from Pfizer and Moderna jumped to the top of the pharma industry's sales charts, displacing longtime stalwarts with unprecedented sales. But, as ...
Pharma | Fierce Pharma
2024年10月14日 · BMS has reported that two phase 3 trials of Sotyktu in psoriatic arthritis have achieved their primary endpoints.
Big Pharma Companies Ranked by Revenue 2022 - Fierce Pharma
2023年4月18日 · While a few companies continued to reap huge profits from COVID products in 2022, others benefited from a return to normalized business operations.
The top 15 blockbuster patent expirations coming this decade
Looking out over the next decade, some of the biggest drugs in the industry will tumble off the patent cliff, putting pharma giants in the hot seat as investors clamor for their next blockbuster.
The top 10 vaccine companies worldwide - Fierce Pharma
What a difference five years—and a global pandemic—can make in reshaping an industry. When Fierce Pharma last published our rankings of the top vaccine players back in 2017, we highlighted the ...
The top 10 generic drug makers by 2021 revenue - Fierce Pharma
Many producers of generic drugs have struggled to achieve growth in recent years due to pricing pressures. But there are promising signs that the industry is ready for an uptick, and they were ...
FDA signs off on first engineered cell therapy for a solid tumor
2024年8月2日 · Adaptimmune has won accelerated FDA approval for Tecelra (afami-cel), a treatment for metastatic or unresectable synovial sarcoma.. Tecelra’s approval comes with several firsts. It’s the first ...